IL150340A0 - Benzoic acid susbstituted benzopyrans for the treatment of atherosclerosis - Google Patents

Benzoic acid susbstituted benzopyrans for the treatment of atherosclerosis

Info

Publication number
IL150340A0
IL150340A0 IL15034002A IL15034002A IL150340A0 IL 150340 A0 IL150340 A0 IL 150340A0 IL 15034002 A IL15034002 A IL 15034002A IL 15034002 A IL15034002 A IL 15034002A IL 150340 A0 IL150340 A0 IL 150340A0
Authority
IL
Israel
Prior art keywords
susbstituted
benzopyrans
atherosclerosis
treatment
benzoic acid
Prior art date
Application number
IL15034002A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL150340A0 publication Critical patent/IL150340A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL15034002A 2001-06-28 2002-06-20 Benzoic acid susbstituted benzopyrans for the treatment of atherosclerosis IL150340A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30171201P 2001-06-28 2001-06-28
US32825401P 2001-10-10 2001-10-10

Publications (1)

Publication Number Publication Date
IL150340A0 true IL150340A0 (en) 2002-12-01

Family

ID=26972559

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15034002A IL150340A0 (en) 2001-06-28 2002-06-20 Benzoic acid susbstituted benzopyrans for the treatment of atherosclerosis

Country Status (12)

Country Link
EP (1) EP1270000A3 (fr)
JP (1) JP2003034638A (fr)
KR (1) KR20030015828A (fr)
CN (1) CN1394602A (fr)
AU (1) AU4239302A (fr)
CA (1) CA2391205A1 (fr)
CZ (1) CZ20022076A3 (fr)
HK (1) HK1049795A1 (fr)
HU (1) HUP0202114A3 (fr)
IL (1) IL150340A0 (fr)
PL (1) PL354770A1 (fr)
SK (1) SK8682002A3 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4476934B2 (ja) * 2003-04-14 2010-06-09 明治乳業株式会社 新規ペプチドおよび免疫賦活剤、機能性食品ならびに機能性食品の製造方法
AU2005266088A1 (en) * 2004-07-22 2006-02-02 Pharmacia Corporation Compositions for treatment of inflammation and pain using a combination of a COX-2 selective inhibitor and a LTB4 receptor antagonist
PT1888033E (pt) * 2005-06-09 2014-05-15 Meda Ab Método e composição para tratamento de distúrbios inflamatórios
US10336733B2 (en) 2015-11-30 2019-07-02 Merk Sharp & Dohme Corp. Aryl acylsulfonamides as BLT1 antagonists
EP3383389B1 (fr) 2015-11-30 2021-04-28 Merck Sharp & Dohme Corp. Utilisation d'arylacylsulfonamides en tant qu'antagonistes de blt1

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3720493A1 (de) * 1987-06-20 1989-01-26 Nattermann A & Cie Arzneizubereitungen mit mikronisierten ebselen-kristallen
MX9300312A (es) * 1992-01-23 1993-07-31 Pfizer Antagonistas benzopiranicos y relacionado de ltb.
DE4228200A1 (de) * 1992-08-25 1994-03-03 Schering Ag Neue Pyridin-Derivate mit Leukotrien-B¶4¶-antagonistischer Wirkung
AU696890B2 (en) * 1994-10-13 1998-09-24 Pfizer Inc. Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B4 (LTB4) antagonists
CA2202056A1 (fr) * 1994-10-13 1996-04-25 Mark A. Dombroski Composes de benzopyranne et composes benzo-fusionnes, leur preparation et leur utilisation comme antagonistes du leucotriene b4' (ltb4)
US6342510B1 (en) * 1995-06-12 2002-01-29 G. D. Searle & Co. Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitors and a leukotriene B4 receptor antagonist
DE19636689A1 (de) * 1996-09-10 1998-03-12 Boehringer Ingelheim Kg Neue Benzamidinderivate
SK31399A3 (en) * 1996-09-16 2000-05-16 Pfizer Processes and intermediates for preparing substituted chromanol derivatives
EP0963755A3 (fr) * 1998-04-16 2001-03-14 Pfizer Products Inc. Utilisation des benzopyranes pour la prévention de rejets de graiffes
WO2000010552A2 (fr) * 1998-08-24 2000-03-02 Global Vascular Concepts, Inc. Utilisation d'agents anti-angiogeniques pour empecher la lesion des parois vasculaires
JP2003225088A (ja) * 1999-09-10 2003-08-12 Meiji Seika Kaisha Ltd ヒト・ロイコトリエンｂ４第二受容体及びそれをコードするｄｎａ
WO2001068844A2 (fr) * 2000-03-17 2001-09-20 Bayer Aktiengesellschaft Regulation du recepteur humain du leucotriene de type b4, couple a la proteine g

Also Published As

Publication number Publication date
KR20030015828A (ko) 2003-02-25
HK1049795A1 (zh) 2003-05-30
JP2003034638A (ja) 2003-02-07
HU0202114D0 (fr) 2002-09-28
AU4239302A (en) 2003-01-02
SK8682002A3 (en) 2004-08-03
CA2391205A1 (fr) 2002-12-28
CZ20022076A3 (cs) 2004-05-12
HUP0202114A2 (hu) 2003-01-28
HUP0202114A3 (en) 2004-07-28
EP1270000A2 (fr) 2003-01-02
CN1394602A (zh) 2003-02-05
PL354770A1 (en) 2002-12-30
EP1270000A3 (fr) 2003-02-12

Similar Documents

Publication Publication Date Title
GB0121985D0 (en) Tissue engineering scaffolds
AU2002360251A8 (en) Medical devices comprising nanocomposites
AU2002342613A8 (en) Treatment for wounds
EP1390029A4 (fr) Phenylindoles pour le traitement de l'infection par le vih
HUP0302847A3 (en) Pharmaceutical formulation comprising bicalutamide
AU2002303502A1 (en) Improved leads for the treatment of patients with chf
PL362671A1 (en) Retinoids for the treatment of emphysema
IL161902A0 (en) Pharmaceutical formulation comprising bicalutamide
EP1460054A4 (fr) Melange d'acide polycarboxylique
IL150340A0 (en) Benzoic acid susbstituted benzopyrans for the treatment of atherosclerosis
AU2002233353A1 (en) Process for the preparation of d-pantothenic acid and/or salts thereof
ZA200402308B (en) NOVEL a-OXYGENATED OR a-THIOLATED CARBOXYLIC ACID PENETHYLAMIDE DERIVATIVES
GB2380481B (en) Means for treatment of atherosclerosis
ZA200205093B (en) Benzoic acid substituted benzopyrans for the treatment of atherosclerosis.
NO20042664L (no) Karboksylsyrederivat
AU2002316940A1 (en) Process for the preparation of d-pantothenic acid and/or salts thereof
GB0123765D0 (en) Para-amino benzoic acids
AU2002304733A1 (en) Amino-aza-cyclohexanes for the treatment of malaria
AU2002364178A8 (en) Ownership of part-physical, part-virtual devices
HUP0402343A3 (en) Substituted beta-aminoalcohols used as medicaments
AU2002240930A1 (en) Process for the preparation of d-pantothenic acid and/or salts thereof
SG122745A1 (en) Compositions for the treatment of malaria
TW518962U (en) Structure for surgical assistance
TJ20010676A (en) Method treatment cirrosis of the liver
AU2002325946A1 (en) Process for the preparation of d-pantothenic acid and/or its salts